Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women
- PMID: 17968839
- DOI: 10.1086/522762
Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women
Abstract
Background: Adherence to therapy is a dynamic behavior. However, few studies have identified factors associated with changes in adherence to highly active antiretroviral therapy (HAART) among men and women.
Methods: From 1999 through 2004, self-reported adherence to HAART was recorded twice yearly as part of 2 prospective cohort studies. At each study visit, participants were categorized as being 100% adherent if they reported full adherence with their HAART regimen over the past 4 days (for men) and 3 days (for women). Repeated-measures logistic regression models were used to identify predictors for changes in adherence between consecutive visits.
Results: Of the participants, 640 men and 1304 women contributed 2803 and 5972 visit-pairs, respectively. Among white men, the prevalence of 100% adherence decreased from 91% in 1998 to 80% in 2003. Among women and African American men, the prevalence of full adherence was lower (75% and 77% on average, respectively) and stable over time (P>.6). In both cohorts, the presence of clinical symptoms was independently associated with decreasing adherence (odds ratio [OR], 1.38 in men and 1.48 in women). Depression in men (OR, 1.44) and use of alcohol in women (OR, 1.81, 1.52, and 1.29, for binge drinking, moderate-to-heavy drinking, and low consumption, respectively) also predicted decreasing adherence. In addition, the use of drugs by men and women (OR, 0.61 and 0.58, respectively) and alcohol binging by women (OR, 0.41) were negatively associated with improving adherence.
Conclusions: Adherence to antiretroviral treatment is a dynamic process; modifiable risk factors are associated with increasing and decreasing adherence, suggesting specific interventions. Moreover, the association of these risk factors with changes in adherence may differ by sex.
Comment in
-
Initial hospitalization and adherence to highly active antiretroviral therapy.Clin Infect Dis. 2008 Mar 15;46(6):957-8. doi: 10.1086/527570. Clin Infect Dis. 2008. PMID: 18288910 No abstract available.
Similar articles
-
Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care.Intern Med J. 2008 Jan;38(1):8-15. doi: 10.1111/j.1445-5994.2007.01477.x. Epub 2007 Oct 3. Intern Med J. 2008. PMID: 17916167
-
Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.Arch Pediatr Adolesc Med. 2005 Aug;159(8):764-70. doi: 10.1001/archpedi.159.8.764. Arch Pediatr Adolesc Med. 2005. PMID: 16061785
-
The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.Addiction. 2008 Nov;103(11):1828-36. doi: 10.1111/j.1360-0443.2008.02323.x. Epub 2008 Sep 4. Addiction. 2008. PMID: 18778390
-
Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.J Antimicrob Chemother. 2009 Sep;64(3):599-606. doi: 10.1093/jac/dkp232. Epub 2009 Jul 14. J Antimicrob Chemother. 2009. PMID: 19602563
-
Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011.Curr HIV/AIDS Rep. 2011 Dec;8(4):277-87. doi: 10.1007/s11904-011-0098-0. Curr HIV/AIDS Rep. 2011. PMID: 21989672 Review.
Cited by
-
Appreciating Reasons for Nonadherence in Women.Health Care Women Int. 2015 Sep;36(9):1007-25. doi: 10.1080/07399332.2014.903952. Epub 2014 May 15. Health Care Women Int. 2015. PMID: 24654887 Free PMC article.
-
Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.AIDS Patient Care STDS. 2014 Mar;28(3):136-43. doi: 10.1089/apc.2013.0329. Epub 2014 Feb 25. AIDS Patient Care STDS. 2014. PMID: 24568654 Free PMC article.
-
Development and Usability of a Smartphone Application for Tracking Antiretroviral Medication Refill Data for Human Immunodeficiency Virus.Methods Inf Med. 2017;56(5):351-359. doi: 10.3414/ME17-01-0045. Epub 2018 Jan 24. Methods Inf Med. 2017. PMID: 29582932 Free PMC article.
-
Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis.J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):181-7. doi: 10.1097/QAI.0b013e31822d490a. J Acquir Immune Defic Syndr. 2011. PMID: 21857529 Free PMC article. Review.
-
Optimization of Multicomponent Behavioral and Biobehavioral Interventions for the Prevention and Treatment of HIV/AIDS.AIDS Behav. 2016 Jan;20 Suppl 1(0 1):S197-214. doi: 10.1007/s10461-015-1145-4. AIDS Behav. 2016. PMID: 26238037 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- 5-M01-RR-00052/RR/NCRR NIH HHS/United States
- M01-RR00079/RR/NCRR NIH HHS/United States
- M01-RR00083/RR/NCRR NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- UO1-AI-35039/AI/NIAID NIH HHS/United States
- UO1-AI-35040/AI/NIAID NIH HHS/United States
- UO1-AI-35041/AI/NIAID NIH HHS/United States
- UO1-AI-35042/AI/NIAID NIH HHS/United States
- UO1-AI-35043/AI/NIAID NIH HHS/United States
- UO1-AI-37613/AI/NIAID NIH HHS/United States
- UO1-AI-37984/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous